2.2.3: Myth #3: Muscle Damage and the Soreness Fallacy

Of all the myths in hypertrophy training, none has been more stubbornly persistent than the belief that Delayed Onset Muscle Soreness (DOMS) is a reliable indicator of a successful growth stimulus. This belief stems from an intuitive but flawed logic: “I damaged the muscle; now it will rebuild bigger and stronger.”

The reality, as a comprehensive body of evidence now demonstrates, is that while some degree of muscle damage is an unavoidable byproduct of unaccustomed or high-tension training, excessive muscle damage is not only unnecessary for hypertrophy but actively interferes with the growth process [8,9].

The damage/adaptation interference paradigm works as follows: when a muscle fiber experiences mechanical stress beyond its current capacity, the sarcomeres and surrounding connective tissue structure can sustain micro-tears and disruption, particularly to the Z-disk and cytoskeletal proteins. The body then mounts an inflammatory response to clear debris and initiate repair. This repair process consumes energy and amino acids that could otherwise be directed toward the accretion of new contractile proteins in undamaged fibers and the ribosome biogenesis that supports long-term growth capacity.

Critically, excessive muscle damage has been shown to impair mTORC1 signaling. The activation of mTORC1, which is the central anabolic kinase responsible for initiating protein synthesis (see Section 1.2), is suppressed in the presence of severe muscle damage. One proposed mechanism involves the competition for cellular resources between the pathways that govern protein degradation (the ubiquitin-proteasome system, activated to clear damaged proteins) and those that govern protein synthesis. A muscle fiber that is dedicating a significant proportion of its translational machinery to producing ubiquitin ligases and proteasome subunits cannot simultaneously maximize the production of myosin and actin. Additionally, the inflammatory cytokines released in response to extensive damage—particularly tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)—can directly inhibit Akt/mTOR signaling [8].

DOMS itself is an exceptionally poor proxy for growth potential for several reasons:

  • It is movement- and novelty-dependent: A lifter who performs a new exercise or emphasizes the eccentric phase will experience significant soreness regardless of the growth stimulus delivered.
  • It habituates: The repeated bout effect means that as a lifter adapts to a given exercise and volume, DOMS diminishes even though the hypertrophic stimulus can remain high. If soreness were the growth signal, the most effective training would be the least consistent—constantly rotating novel exercises to maximize damage—which is precisely the opposite of what allows for progressive overload and systematic growth.
  • It can coexist with no growth: Stretch-mediated damage protocols, such as extreme downhill running, produce profound DOMS with little to no hypertrophy, because the motor unit recruitment and mechanical tension during the activity are insufficient [9].
  • It is uncorrelated with long-term hypertrophy outcomes: In well-controlled longitudinal studies, the degree of initial muscle damage (as measured by creatine kinase, MRI T2 signal, or subjective soreness) does not predict the magnitude of muscle growth over a training block [8].

The practical takeaway is clear: chase performance, not soreness. A well-designed program will produce some degree of soreness in the early stages of a new mesocycle or when novel exercises are introduced, but persistent, debilitating DOMS that compromises subsequent training sessions is a sign of excessive damage, not a marker of an effective growth stimulus. The goal is to provide a mechanical tension signal that is sufficient to activate mTORC1 and stimulate ribosome biogenesis while managing the dose so that damage remains within the range that can be repaired without suppressing the anabolic response. This is precisely why proximity to failure, volume, and exercise selection must be intelligently regulated (see Chapter 5)—and why the modern lifter should abandon the destructive quest to be sore after every session.